Sign in
4

Changes in Ownership

Actinium Pharmaceuticals, Inc. Filed Acc 0001213900-18-004773

Chairman & CEO bought 5,000 shares at $0.38 ($1,900)

From the SEC's structured data for this filing

Trades in this filing

SETH SANDESH · Chairman & CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2018-04-19 Purchase : show line 1 in the form +5,000 $0.38 $1,900 133,333 D
Open-market purchases · 5,000 sh · avg $0.38 · $1,900
Loading xslF345X03/f4041918seth_actiniumpharma.xml…